A selection the whole field trusts.
Expert reviewers, live pitches, and a strategic selection committee surface the strongest companies from a deep applicant pool. By the time a company is in, the market has already vetted it.
We mobilize the full power of the global medtech community to move the most promising medical device, diagnostic, and digital health innovations past the barriers between innovation and the patient.
Building medtech is uniquely hard. The regulatory path is long, the capital needs are steep, and the buyers are the most demanding in any industry. We help you through all of it, and connect you with the partners who can bring your technology to patients at scale.
Learn about the ProgramWe connect you with the most promising companies in medtech, the intelligence to track where the field is going, and the community building its future.
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
:format(webp))
Every cohort is filtered down to the most credible early-stage companies in the field, so your time goes to the ones worth it.
See the technologies and teams reshaping your category before anyone else does.
Stand alongside the industry leaders defining where medtech goes next.
Select your role to see how MTI moves your goals forward.
:format(webp))
“MedTech Innovator takes the time to really understand what meets with our strategy and then basically curates a list of companies that are great matches for us… There are two companies that were MedTech Innovator companies that we actually ended up acquiring [Endotronics and Vectorious]. And we’ve had a number that we’ve invested in over the years.”
:format(webp))
Four advantages no other accelerator can offer at once, from the moment a company applies to the day it reaches the market.
:format(webp))
Expert reviewers, live pitches, and a strategic selection committee surface the strongest companies from a deep applicant pool. By the time a company is in, the market has already vetted it.
The companies that partner with and acquire medtech startups help select and mentor every cohort. Founders hear directly from the people they’re building toward, long before a deal is on the table.
A first-in-human study and a commercial launch need different things. Programming adapts to each company’s stage, so the support fits the moment instead of a fixed curriculum.
A live benchmark tracking growth, survival, and commercial traction across the portfolio.
Source: HSBC Innovation Banking, 2025 Venture Healthcare Report (opens in a new tab)
Explore the sectors and therapeutic areas our companies are advancing. Choose a category to filter the field.
Selected groups
Devices & Hardware
570
companies advancing in Devices & Hardware
:format(webp))
Samay is developing Sylvee, an AI-powered wearable designed to detect COPD before spirometry can, enabling earlier and more accessible respiratory disease detection for the millions of people who need it.
:format(webp))
NeoCast is a solvent-free, non-adhesive biomaterial engineered to achieve microvascular occlusion. EMBO-01 is the first-in-human trial of NeoCast for the pre-surgical embolization of hypervascular brain tumors.
:format(webp))
Hamilton Company, a global life sciences and laboratory technology company, has acquired Charlottesville-based, University of Virginia spin-off company Cerillo.
:format(webp))
“MTI is really a huge tailwind behind any company. MTI has helped us by providing resources and really just getting us out there in front of other folks. People have come up to us and said, ‘Oh, yeah, you’re an MTI company.’ So the branding—the MTI branding—has been huge for us…”
:format(webp))
:format(webp))
“If you get in, you are going to come out in a completely different fashion—much more advanced, better equipped, and with a network of people that understands you. Really, you can come out from this impactful experience as a completely new company.”
:format(webp))
:format(webp))
“The reason to participate in MTI is to take something that feels incredibly isolationist and hard, and make it a team sport. Build that tribe that’s going to get you through the finish line, and give you active criticism in a friendly, safe space, instead of learning it the hard way.”
:format(webp))
:format(webp))
MTI joins AdvaMed at The MedTech Conference in Boston, October 18–21. All 65 of the 2026 cohort are featured at the MedTech Innovator Showcase, and four finalists compete live for the grand prize on October 20.
2026 Grand Finals · Oct 20
$350,000
Cash prize. Four finalists. Selected by live audience vote.
The latest news, announcements, and insights from MedTech Innovator, our portfolio companies, and the broader medtech community.

Dr. Jeffrey Shuren, former Director of the FDA's Center for Devices and Radiological Health, joins MedTech Innovator as an Advisor to guide portfolio companies on regulatory strategy and market access.

Zonova, which aims to make infection-resistant medical devices the new standard of care, won the 2026 Vision Award by live audience vote at Wilson Sonsini's 33rd Annual Medical Device Digital Health Conference.
:format(webp))
MedTech Innovator announced the 65 companies in its 2026 Accelerator Cohort — the top 4% of 1,835 global applicants — and launched the MTI Index, a recognition platform that makes the MTI portfolio discoverable by investors, health systems, and media.
:format(webp))
:format(webp))
A family of accelerator programs built on the same proven model: give exceptional founders the visibility, mentorship, and connections they need to succeed.
:format(webp))
The flagship accelerator for medical device, diagnostic, and digital health startups.
:format(webp))
The same model, tuned for founders building across the Asia Pacific region.
:format(webp))
For the teams building the tools that power the next generation of life science.